Colorectal cancer (CRC) is one of the most frequently occurring malignancy tumors with a
high morbidity additionally, CRC patients may develop liver metastasis, which is the major …

Malignant liver tumours include a wide range of primary and secondary tumours. Although
surgery remains the mainstay of curative treatment, modern therapies integrate a variety of …

Colorectal cancer (CRC) is one of the most common malignancies in Western countries.
Over the last 20 years, and the last decade in particular, the clinical outcome for patients with …

Background Tumor ablation is often employed for unresectable colorectal liver metastases.
However, no survival benefit hasever been demonstrated in prospective randomized …

The liver is the commonest site of metastatic disease for patients with colorectal cancer, with
at least 25% developing colorectal liver metastases (CRLM) during the course of their …

Objective: To apply the principles of the Metro-ticket paradigm to develop a prognostic
model for patients undergoing hepatic resection of colorectal liver metastasis (CRLM) …

Colorectal cancer (CRC) is the most common tumour type in both sexes combined in
Western countries. Although screening programmes including the implementation of faecal …

PURPOSE This trial investigated the addition of panitumumab to triplet chemotherapy with
fluorouracil/folinic acid, oxaliplatin, and irinotecan (FOLFOXIRI) in a two-to-one randomized …

Background Hepatic metastases develop in approximately 50% of colorectal cancer (CRC)
cases. We performed a review and meta-analysis to evaluate survival after resection of CRC …

An international panel of multidisciplinary experts convened to develop recommendations
for the management of patients with liver metastases from colorectal cancer (CRC). The aim …